scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1468-2982.1995.1506489.X |
P698 | PubMed publication ID | 8706112 |
P2093 | author name string | T L Yaksh | |
J F Rothrock | |||
A C Moore | |||
A Golbeck | |||
K R Mar | |||
P2860 | cites work | On serotonin and migraine: a clinical and pharmacological review | Q28263827 |
Taurine levels in plasma and cerebrospinal fluid in migraine patients | Q34729562 | ||
Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. | Q41338044 | ||
Suboccipital cerebrospinal fluid and plasma concentrations of somatostatin, neuropeptide Y and beta-endorphin in patients with common migraine | Q43613895 | ||
Platelet Glycine, Glutamate and Aspartate in Primary Headache | Q46199099 | ||
Evidence of alpha-N-acetyl beta-endorphin in human cerebrospinal fluid | Q48454865 | ||
Endorphin patterns within the headache spectrum disorders | Q48493897 | ||
A pharmacological investigation of cerebro-spinal fluid from patients with migraine | Q51201127 | ||
Excretion of free and conjugated 5-HIAA and VMA in urine and concentration of 5-HIAA and HVA in CSF during migraine attacks and free intervals | Q53939422 | ||
Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. | Q55062025 | ||
Cerebrospinal fluid gamma aminobutyric acid levels in migraine | Q55154931 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebrospinal fluid | Q54196 |
migraine | Q133823 | ||
P304 | page(s) | 489-493 | |
P577 | publication date | 1995-12-01 | |
P1433 | published in | Cephalalgia | Q5063251 |
P1476 | title | Cerebrospinal fluid analyses in migraine patients and controls | |
P478 | volume | 15 |
Q28834117 | A 'complex' of brain metabolites distinguish altered chemistry in the cingulate cortex of episodic migraine patients |
Q53329143 | Aminergic tone correlates of migraine and tension-type headache: a study using the tridimensional personality questionnaire. |
Q38121110 | Biomarkers associated with migraine and their potential role in migraine management |
Q37801392 | Brain Imaging in Migraine Research |
Q36546364 | Cerebrospinal fluid biomarkers in primary headache disorders |
Q45021407 | Cerebrospinal fluid glutamate levels in chronic migraine |
Q41460262 | Clinical studies of valproate for migraine prophylaxis |
Q34124786 | Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model |
Q37271327 | Excitatory neurotransmitters in brain regions in interictal migraine patients |
Q35658661 | Genotype-phenotype correlation in migraine without aura focusing on the rs1835740 variant on 8q22.1. |
Q56618727 | Increased Cerebrospinal Fluid Glycine: A Biochemical Marker for a Leukoencephalopathy With Vanishing White Matter |
Q41572995 | Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine |
Q38140024 | Is the migrainous brain normal outside of acute attacks? Lessons learned from psychophysical, neurochemical and functional neuroimaging studies |
Q45304283 | Metabolic assessment of a migraine model using relaxation-enhanced 1 H spectroscopy at ultrahigh field |
Q39297448 | Metabolomic changes in CSF of migraine patients measured with 1H-NMR spectroscopy |
Q44919937 | Monoaminergic transmitters in the cerebrospinal fluid of patients with acute, chronic, and intermittent pain. Interface between pain and depression? |
Q37140513 | Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome |
Q37394217 | Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease). |
Q52090356 | Patterns of functional brain organization and migraine. |
Q36546368 | Selected confirmed, probable, and exploratory migraine biomarkers. |
Q57021546 | What Are We Missing in the Diagnostic Criteria for Migraine? |
Q34372024 | What's in a name? tension-type headache versus migraine |